Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 153, Issue 4, Pages 421-436Publisher
WILEY
DOI: 10.1111/j.1365-2141.2011.08595.x
Keywords
flow cytometry; aberrant antigen expression; acute myeloid leukaemia; myelodysplastic syndromes; minimal residual disease
Categories
Ask authors/readers for more resources
P>This article reviews the use of aberrant antigen expression detected by flow cytometry in the diagnosis and clinical handling of acute myeloid leukaemia (AML) and the myelodysplastic syndromes (MDS). Such aberrancies offer a valuable tool for the proper classification of these myeloid malignancies according the World Health Organization 2008 classification. Aberrant antigen expression by flow cytometry is also important for prognostification. This review supports the view, that minimal residual disease detection methods that make use of such aberrancies should be part of the routine management of AML patients to guide therapy, but also suggests the introduction of flow cytometry in MDS for diagnosis and treatment decisions in the near future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available